Tiamat is developing a plant molecular farming technology to manufacture affordable growth factors & other proteins that will make cell-based meats a mainstream alternative.
Tiamat’s unique technology affords a superior manufacturing flexibility, with their production system costing 60X less than current cellular agriculture competitors, and a scale-up potential to meet clean-meat requirements.
Cell-based meat companies are still missing key ingredients to scale their production: affordable animal-free growth factors & culture medium. Today, the culture media accounts for up to 80% of the total production cost of cellular ag, representing a major limitation in scalability.
Through their new solution, PlanTech, which combines pre-installed infrastructure and vertical farming, Tiamat is on a mission to supply cellular agriculture companies with 50% of their inputs by 2040.